MAIA Biotechnology, Inc. Public Float
MAIA Biotechnology, Inc. (MAIA) had Public Float of $48.95 million as of 2025-06-30, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-23
- 2025-06-30: Entity Public Float $48.95M.
- 2024-06-30: Entity Public Float $67.46M.
- 2023-06-30: Entity Public Float $22.48M.
- 2022-06-30: Entity Public Float $0.00.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $48.95M 10-K · filed 2026-03-23 |
| 2024-06-30 | $67.46M 10-K · filed 2025-03-21 |
| 2023-06-30 | $22.48M 10-K · filed 2024-03-21 |
| 2022-06-30 | $0.00 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |